8月 2026Shifamed的市場佔有率分析

The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System Campbell, Calif., August 12, 2025 - Myra Vision, a Shifamed portfolio company, announced today that the U.S. Food and Drug Administration (FDA) has issued a conditional approval letter for its Investigational Device Exemption (IDE) application to

工作和職業 > 人力資源

域名shifamed.com

成立年份2001

僱員51 - 200

年度營收$15M - $25M

Shifamed

Shifamed（包含公司地區）

shifamed.com

查看更多網站流量與參與度資訊

Shifamed截至 8月 2026 的總收入為 15M - 25M

Shifamed 熱門網域產生的總收入

Shifamed 熱門網域 3 年內的總收入

Shifamed 熱門網域的總收入

shifamed.com15M - 25M

透過銷售情報查看更多內容

Shifamed的熱門網域總造訪量

了解Shifamed市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

shifamed.com3K

透過銷售情報查看更多內容

Shifamed的熱門網域平均造訪時長

分析Shifamed參與度指標。

過去 3 個月平均造訪時長

子公司細目

shifamed.com00:00:37

透過銷售情報查看更多內容

Shifamed的熱門網域平均頁面瀏覽量

了解Shifamed如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

shifamed.com1.80

透過銷售情報查看更多內容

Shifamed按網域劃分的熱門競爭對手

8月 2026的熱門類似網站，依相似度排名

lifesciencemarketresearch.com公司名Life Science Market Research a Life S...僱員51 - 200總部美國, 加利福尼亞, Huntington Beach年度營收$15M - $25M訪問總量11.7K健康 > 健康 - 其他

使用的熱門技術Shifamed

这些是Shifamed顶级域名使用的行业网站技术

音訊視訊媒體 (4)

YouTube

內容管理系統 (3)

WordPress

轉換與分析 (3)

Google Analytics

付費廣告 (2)

DoubleClick

更多技術

7

檢視所有

新聞與訊號來自Shifamed

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Shifamed, LLC acquires Nuveramedical.Shifamed LLC, a highly specialized medical innovation hub, publicly announces the acquisition of NuVera Medical to Biosense Webster, the global leader in cardiac arrhythmia treatment and part of the Johnson & Johnson Medical Device Companies *.

新聞Shifamed, LLC hires Brian Fahey as Chief Executive Officer.Additionally, Shifamed announced the appointment of experienced medical device executive, Brian Fahey, as Adona Medical's Chief Executive Officer.

新聞Shifamed, LLC hires Robert Chang as strategic advisor.Additionally, Shifamed announced the appointments of Robert Chang to serve as Myra Medical's Chief Executive Officer and Tracy Valorie, seasoned ophthalmology executive, to serve as strategic advisor to the company.